In a preliminary report of its 2025 results, Apellis said that sales of its geographic atrophy (GA) drug Syfovre came in at ...

Some of the top-grossing drugs include Merck's Keytruda, an immunotherapy for multiple cancers with almost $30 billion in ...

BAYRY jumps 6.6% after partner Orion said Nubeqa sales tied to Bayer could top ???1B long term. Bayer also announced pharma ...

With sluggish pharmaceutical sales in the third quarter coming in below analysts’ expectations, Bayer is acutely aware of the challenges facing its key unit. Nevertheless, at least as far as ...

2025 might shape out to be a boon year for pharma, a recent report from Norstella’s Evaluate suggests. The 2025 Preview Report examines the “biggest movers and shakers” in the biotech and pharma ...

CEO David Zaccardelli highlighted the continued success of the Ohtuvayre launch for COPD maintenance treatment, with net product sales of $71.3 million in Q1 2025, nearly doubling from the previous ...

What Happened? Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell 5.3% in the afternoon session ...

Ascentage Pharma reported 2024 sales of $134.3M, up 342% YoY, driven by a $100M option payment from Takeda under an exclusive agreement. JP Morgan initiated Ascentage Pharma with an Overweight rating ...

The pharmaceutical industry is the cornerstone of drug development, commercialization and marketing. According to Statista, pharma sector revenues topped US$1 trillion for the first time in 2014, and ...

The latest announcement is out from Solasia Pharma KK ( (JP:4597)). Solasia Pharma K.K. has announced a change in its sales partner for the oral liquid product, episil, in China. The company is ...